QIAGEN N.V. (QIA.DE) Stock Fundamental Analysis
Europe - Frankfurt Stock Exchange - FRA:QIA - NL0015002CX3 - Common Stock
38.985 EUR
-0.13 (-0.35%)
Taking everything into account, QIA scores 7 out of 10 in our fundamental rating. QIA was compared to 21 industry peers in the Life Sciences Tools & Services industry. Both the health and profitability get an excellent rating, making QIA a very profitable company, without any liquidiy or solvency issues. QIA has a decent growth rate and is not valued too expensively. With these ratings, QIA could be worth investigating further for quality investing!.
1. Profitability
1.1 Basic Checks
QIA had positive earnings in the past year.
In the past year QIA had a positive cash flow from operations.
In the past 5 years QIA has always been profitable.
QIA had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
Looking at the Return On Assets, with a value of 6.19%, QIA is in the better half of the industry, outperforming 71.43% of the companies in the same industry.
Looking at the Return On Equity, with a value of 11.11%, QIA is in the better half of the industry, outperforming 76.19% of the companies in the same industry.
With a decent Return On Invested Capital value of 7.44%, QIA is doing good in the industry, outperforming 66.67% of the companies in the same industry.
QIA had an Average Return On Invested Capital over the past 3 years of 7.25%. This is in line with the industry average of 9.19%.
The last Return On Invested Capital (7.44%) for QIA is above the 3 year average (7.25%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.19% | ||
| ROE | 11.11% | ||
| ROIC | 7.44% |
ROA(3y)4.59%
ROA(5y)5.65%
ROE(3y)7.84%
ROE(5y)10.58%
ROIC(3y)7.25%
ROIC(5y)7.96%
1.3 Margins
QIA has a better Profit Margin (19.58%) than 95.24% of its industry peers.
QIA's Profit Margin has declined in the last couple of years.
QIA's Operating Margin of 27.02% is amongst the best of the industry. QIA outperforms 95.24% of its industry peers.
In the last couple of years the Operating Margin of QIA has grown nicely.
QIA's Gross Margin of 64.10% is amongst the best of the industry. QIA outperforms 90.48% of its industry peers.
In the last couple of years the Gross Margin of QIA has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 27.02% | ||
| PM (TTM) | 19.58% | ||
| GM | 64.1% |
OM growth 3Y-5.04%
OM growth 5Y4.09%
PM growth 3Y-42.96%
PM growth 5YN/A
GM growth 3Y-0.32%
GM growth 5Y-0.63%
2. Health
2.1 Basic Checks
QIA has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
QIA has less shares outstanding than it did 1 year ago.
The number of shares outstanding for QIA has been reduced compared to 5 years ago.
QIA has a better debt/assets ratio than last year.
2.2 Solvency
An Altman-Z score of 3.51 indicates that QIA is not in any danger for bankruptcy at the moment.
QIA has a better Altman-Z score (3.51) than 66.67% of its industry peers.
QIA has a debt to FCF ratio of 4.50. This is a neutral value as QIA would need 4.50 years to pay back of all of its debts.
QIA's Debt to FCF ratio of 4.50 is fine compared to the rest of the industry. QIA outperforms 76.19% of its industry peers.
QIA has a Debt/Equity ratio of 0.45. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.45, QIA is in the better half of the industry, outperforming 71.43% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.45 | ||
| Debt/FCF | 4.5 | ||
| Altman-Z | 3.51 |
ROIC/WACC0.9
WACC8.26%
2.3 Liquidity
QIA has a Current Ratio of 2.60. This indicates that QIA is financially healthy and has no problem in meeting its short term obligations.
QIA has a Current ratio of 2.60. This is amongst the best in the industry. QIA outperforms 90.48% of its industry peers.
QIA has a Quick Ratio of 2.30. This indicates that QIA is financially healthy and has no problem in meeting its short term obligations.
QIA has a Quick ratio of 2.30. This is amongst the best in the industry. QIA outperforms 90.48% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.6 | ||
| Quick Ratio | 2.3 |
3. Growth
3.1 Past
QIA shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 9.62%, which is quite good.
The Earnings Per Share has been growing by 8.40% on average over the past years. This is quite good.
QIA shows a small growth in Revenue. In the last year, the Revenue has grown by 5.32%.
QIA shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 5.32% yearly.
EPS 1Y (TTM)9.62%
EPS 3Y-6.66%
EPS 5Y8.4%
EPS Q2Q%4.04%
Revenue 1Y (TTM)5.32%
Revenue growth 3Y-4.22%
Revenue growth 5Y5.32%
Sales Q2Q%6.09%
3.2 Future
Based on estimates for the next years, QIA will show a quite strong growth in Earnings Per Share. The EPS will grow by 9.54% on average per year.
The Revenue is expected to grow by 7.12% on average over the next years.
EPS Next Y9.25%
EPS Next 2Y8.01%
EPS Next 3Y8.58%
EPS Next 5Y9.54%
Revenue Next Year5%
Revenue Next 2Y5.57%
Revenue Next 3Y5.79%
Revenue Next 5Y7.12%
3.3 Evolution
The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 19.40 indicates a rather expensive valuation of QIA.
QIA's Price/Earnings ratio is a bit cheaper when compared to the industry. QIA is cheaper than 71.43% of the companies in the same industry.
QIA is valuated rather cheaply when we compare the Price/Earnings ratio to 26.59, which is the current average of the S&P500 Index.
The Price/Forward Earnings ratio is 17.73, which indicates a rather expensive current valuation of QIA.
Based on the Price/Forward Earnings ratio, QIA is valued a bit cheaper than the industry average as 71.43% of the companies are valued more expensively.
QIA is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 24.03, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 19.4 | ||
| Fwd PE | 17.73 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of QIA indicates a somewhat cheap valuation: QIA is cheaper than 71.43% of the companies listed in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of QIA indicates a somewhat cheap valuation: QIA is cheaper than 76.19% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 21.09 | ||
| EV/EBITDA | 13.43 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates QIA does not grow enough to justify the current Price/Earnings ratio.
QIA has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)2.1
PEG (5Y)2.31
EPS Next 2Y8.01%
EPS Next 3Y8.58%
5. Dividend
5.1 Amount
With a yearly dividend of 0.56%, QIA is not a good candidate for dividend investing.
QIA's Dividend Yield is a higher than the industry average which is at 0.54.
Compared to an average S&P500 Dividend Yield of 1.87, QIA's dividend is way lower than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.56% |
5.2 History
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
DPN/A
EPS Next 2Y8.01%
EPS Next 3Y8.58%
FRA:QIA (12/23/2025, 7:00:00 PM)
38.985
-0.13 (-0.35%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)
Earnings (Next)
Inst Owners84.59%
Inst Owner ChangeN/A
Ins Owners0.44%
Ins Owner ChangeN/A
Market Cap8.45B
Revenue(TTM)2.07B
Net Income(TTM)405.37M
Analysts74.17
Price Target44.35 (13.76%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.56% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-0.14%
Min EPS beat(2)-2.4%
Max EPS beat(2)2.11%
EPS beat(4)2
Avg EPS beat(4)0.92%
Min EPS beat(4)-3.85%
Max EPS beat(4)7.8%
EPS beat(8)5
Avg EPS beat(8)1.59%
EPS beat(12)8
Avg EPS beat(12)2.59%
EPS beat(16)12
Avg EPS beat(16)5.18%
Revenue beat(2)0
Avg Revenue beat(2)-0.42%
Min Revenue beat(2)-0.72%
Max Revenue beat(2)-0.12%
Revenue beat(4)1
Avg Revenue beat(4)-0.33%
Min Revenue beat(4)-1.92%
Max Revenue beat(4)1.43%
Revenue beat(8)1
Avg Revenue beat(8)-0.6%
Revenue beat(12)2
Avg Revenue beat(12)-0.64%
Revenue beat(16)6
Avg Revenue beat(16)0.46%
PT rev (1m)-0.67%
PT rev (3m)-0.54%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-1.96%
EPS NY rev (1m)0.64%
EPS NY rev (3m)1.27%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-1.91%
Revenue NY rev (1m)-0.24%
Revenue NY rev (3m)-0.24%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 19.4 | ||
| Fwd PE | 17.73 | ||
| P/S | 4.81 | ||
| P/FCF | 21.09 | ||
| P/OCF | 15.15 | ||
| P/B | 2.73 | ||
| P/tB | 12.49 | ||
| EV/EBITDA | 13.43 |
EPS(TTM)2.01
EY5.16%
EPS(NY)2.2
Fwd EY5.64%
FCF(TTM)1.85
FCFY4.74%
OCF(TTM)2.57
OCFY6.6%
SpS8.1
BVpS14.28
TBVpS3.12
PEG (NY)2.1
PEG (5Y)2.31
Graham Number25.41
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.19% | ||
| ROE | 11.11% | ||
| ROCE | 10.03% | ||
| ROIC | 7.44% | ||
| ROICexc | 10.67% | ||
| ROICexgc | 39.98% | ||
| OM | 27.02% | ||
| PM (TTM) | 19.58% | ||
| GM | 64.1% | ||
| FCFM | 22.82% |
ROA(3y)4.59%
ROA(5y)5.65%
ROE(3y)7.84%
ROE(5y)10.58%
ROIC(3y)7.25%
ROIC(5y)7.96%
ROICexc(3y)9.42%
ROICexc(5y)10.13%
ROICexgc(3y)34.6%
ROICexgc(5y)42.77%
ROCE(3y)9.77%
ROCE(5y)10.73%
ROICexgc growth 3Y-31.24%
ROICexgc growth 5Y-2.41%
ROICexc growth 3Y-13.09%
ROICexc growth 5Y6.48%
OM growth 3Y-5.04%
OM growth 5Y4.09%
PM growth 3Y-42.96%
PM growth 5YN/A
GM growth 3Y-0.32%
GM growth 5Y-0.63%
F-Score8
Asset Turnover0.32
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.45 | ||
| Debt/FCF | 4.5 | ||
| Debt/EBITDA | 2.17 | ||
| Cap/Depr | 97.52% | ||
| Cap/Sales | 8.94% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 87.76% | ||
| Profit Quality | 116.56% | ||
| Current Ratio | 2.6 | ||
| Quick Ratio | 2.3 | ||
| Altman-Z | 3.51 |
F-Score8
WACC8.26%
ROIC/WACC0.9
Cap/Depr(3y)78.4%
Cap/Depr(5y)95.94%
Cap/Sales(3y)7.97%
Cap/Sales(5y)9.87%
Profit Quality(3y)273.85%
Profit Quality(5y)189.74%
High Growth Momentum
Growth
EPS 1Y (TTM)9.62%
EPS 3Y-6.66%
EPS 5Y8.4%
EPS Q2Q%4.04%
EPS Next Y9.25%
EPS Next 2Y8.01%
EPS Next 3Y8.58%
EPS Next 5Y9.54%
Revenue 1Y (TTM)5.32%
Revenue growth 3Y-4.22%
Revenue growth 5Y5.32%
Sales Q2Q%6.09%
Revenue Next Year5%
Revenue Next 2Y5.57%
Revenue Next 3Y5.79%
Revenue Next 5Y7.12%
EBIT growth 1Y18.55%
EBIT growth 3Y-9.05%
EBIT growth 5Y9.63%
EBIT Next Year56.15%
EBIT Next 3Y22.11%
EBIT Next 5Y15.78%
FCF growth 1Y71.67%
FCF growth 3Y5.12%
FCF growth 5Y55.1%
OCF growth 1Y52.1%
OCF growth 3Y1.77%
OCF growth 5Y15.28%
QIAGEN N.V. / QIA.DE FAQ
What is the fundamental rating for QIA stock?
ChartMill assigns a fundamental rating of 7 / 10 to QIA.DE.
What is the valuation status of QIAGEN N.V. (QIA.DE) stock?
ChartMill assigns a valuation rating of 5 / 10 to QIAGEN N.V. (QIA.DE). This can be considered as Fairly Valued.
How profitable is QIAGEN N.V. (QIA.DE) stock?
QIAGEN N.V. (QIA.DE) has a profitability rating of 8 / 10.
What is the valuation of QIAGEN N.V. based on its PE and PB ratios?
The Price/Earnings (PE) ratio for QIAGEN N.V. (QIA.DE) is 19.4 and the Price/Book (PB) ratio is 2.73.
How financially healthy is QIAGEN N.V.?
The financial health rating of QIAGEN N.V. (QIA.DE) is 8 / 10.